Aging Clinical Trials

A listing of Aging medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Xenoscience
Phoenix Arizona 85004

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

View More ▼

Glendale Arizona 85302

Effect of Dietary Supplementation on Dynamic Stability

California

Alliance Research Center
Laguna Hills California 92653

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Renew Behavioral Health, Inc.
Long Beach California 90807

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Excell Research, Inc.
Oceanside California 92056

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Asclepes Research Center
Panorama City California 91402

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Northern California Research
Sacramento California 95821

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

San Francisco Clinical Research Center
San Francisco California 94530

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

View More ▼

Monterey California 93940

A clinical study for patients with Aging

Palo Alto California 94304

Patients are needed to participate in a clinical research study evaluating Neuropsychological testing for the treatment of HIV or AIDS

Florida

Bradenton Research Center
Bradenton Florida 34205

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Cardiology Research Associates
Daytona Beach Florida 32117

Type II Diabetic Patients at High Risk For Cardiovascular Events

MD Clinical
Hallandale Beach Florida 33009

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

IMIC, Inc.
Miami Florida 33157

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Panax Clincial Research LLC
Miami Lakes Florida 33014

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Lazlo Mate, MD
North Palm Beach Florida 33408

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Neurostudies, Inc.
Port Charlotte Florida 33952

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Progressive Medical Research
Port Orange Florida 32127

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Stedman Clinical Trials
Tampa Florida 33613

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

View More ▼

Orlando Florida 32827

A clinical trial seeking patients for a research study for the treatment of Health Behavior, Quality of Life or Aging

The Villages Florida 32162

A clinical research study for the treatment of Early Onset Alzheimer Disease, Mild Cognitive Impairment, Depression or Aging

Illinois

Behavioral Health Care Associates
Schaumburg Illinois 60193

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Kansas

Precise Clinical Research
Topeka Kansas 66604

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Kentucky

University of Kentucky Chandler Medical Center
Lexington Kentucky 40536

Early Detection and Prevention of Mild Cognitive Impairment Due to Cerebrovascular Disease

University of Kentucky Chandler Medical Center
Lexington Kentucky 40536

Understanding the Emotions of Caregivers in Kentucky

Maine

Eastern Maine Medical Center
Bangor Maine 04401

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Massachusetts

ActiveMed
Methuen Massachusetts 01844

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

View More ▼

Boston Massachusetts 02114

A clinical research study of Testosterone, Anastrazole and Goserelin acetate for the treatment of Healthy Volunteers

Missouri

Washington University in St. Louis - Center for Clinical Studies
Saint Louis Missouri 63110

A Washington University memory research study seeks participants 60 to 85 years old.

Washington University in St. Louis - Center for Clinical Studies
St. Louis Missouri 63130

A Washington University research study seeks participants for an online survey.

New Hampshire

ActiveMed
Portsmouth New Hampshire 03801

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

New Jersey

Memory Enhancement Center of America
Eatontown New Jersey 07724

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Premier Urology Associates, LLC
Lawrenceville New Jersey 08648

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

The NeuroCognitive Institute
Mt. Arlington New Jersey 07856

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

New Mexico

Albuquerque Neuroscience
Albuquerque New Mexico 87109

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

New York

Medical Research Network
New York New York 10128

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Manhattan Behavioral Medicine
New York New York 10023

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Winifred Masterson Burke Medical Research Institute
White Plains New York 10605

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

North Carolina

ANI Neurology, PLLC Alzheimer's Memory Center
Charlotte North Carolina 28270

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

PMG Research of Winston-Salem
Winston-Salem North Carolina 27103

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Ohio

Columbus Research & Wellness Institute
Columbus Ohio 31904

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Oklahoma

Cutting Edge Research Group
Oklahoma City Oklahoma 73116

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Tulsa Clinical Research, Inc.
Tulsa Oklahoma 74114

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Pennsylvania

Pearl Clinical Research
Norristown Pennsylvania 19401

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Thomas Jefferson University
Philadelphia Pennsylvania 19107

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

South Carolina

Metrolina Neurological Associates, PA
Rock Hill South Carolina 29732

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Texas

ACRC Trials
Plano Texas 75024

Type 2 Diabetes with a high risk of Cardivascular Events

Grayline Clinical Drug Trials
Wichita Falls Texas 76309

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Utah

Wasatch Clinical Research
Salt Lake City Utah 84107

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease

Washington

Summit Research Network (Seattle), Inc.
Seattle Washington 29732

A Phase III Safety and Efficacy Study of ALZT-OP1 in Individuals With Evidence of Early Alzheimer's Disease